Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs

For over six decades reductionist approaches to cancer chemotherapies including recent immunotherapy for solid tumors produced outcome failure-rates of 90% ( ±5) according to governmental agencies and industry....
Source: Clinical and Translational Medicine - Category: Internal Medicine Authors: Tags: Perspective Source Type: research